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SUMMARY 
Group-housed adult male Sprague-Dawley rats were given a series of 4 exposures 
to electroconvulsive shock therapy or equivalent handling without shock (sham 
treatment). Twenty-four hours after the final treatment the rats were given vehicle 
or one of two doses of morphine intraperitoneally, and motor activity was assessed 
by remote sensing for 60 min. A significant shift of the normal dose-response curve 
towards the right was seen after electroshock. This may point to cross-tolerance 
between electroshock and opiates upon this behavioral measure. The results are 
consistent with the hypothesis that endorphins may mediate certain aspects of 
electroshock. 
Electroconvulsive shock therapy (ECT) is one of the most effective of somatic 
therapies for endogenous depression and certain subtypes of schizophrenia [4]. It 
remains a therapy of choice for otherwise refractory cases of severe 
psychopathology, especially long-standing but pharmacotherapeutically resistant 
depressions [4]. The underlying psychobiological mechanisms through which ECT 
exerts its therapeutic effects are not established, although biogenic amines have been 
hypothesized to play a critical role [3-5, 11]. Recently it has been suggested that 
endogenous opioid neuropeptides may also be involved in many of the physiological 
and behavioral changes brought about by ECT. Several lines of evidence support 
this view. Clinically, ECT has some established analgesic properties in cases of 
chronic pain [11, 13]. Preclinically, ECT induces opiate-like changes in respiration, 
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thermoregulation, pain sensitivity and catalepsy, all of  which are attenuated by the 
post-synaptic blocker naloxone [1, 2]. 
Selected doses of  opiates, particularly lower doses, are also known to produce an 
increase in locomotor  activity [7]. Since ECT itself produces a state of  opiate-like 
catalepsy, and since this effect is more typical of  higher degrees of  opiate 
stimulation, it is difficult to directly assess whether ECT has any effects related to 
the lower-dose opiate-elicited activation effect. One possible means of  further 
evaluating this issue, however, is to examine the cross-tolerance of ECT and 
morphine with respect to drug-induced activity. It is possible that pretreatment with 
ECT might produce behavioral tolerance to the activating effects of  morphine 
similar to those produced by morphine itself. This was examined in the present 
investigation. 
Eighty-four adult (70 day) male Sprague-Dawley  rats (n -- 12/cell, Charles River 
Farms) were group housed with food (Teklad 4.0% fat diet S-0836) and tap water 
continuously available and 12 h/12 h lighting cycles (lights on at 07.00-19.00 h). 
Motor  activity was monitored upon commercially available tuned oscillators 
(Stoelting, Chicago) which have been described in detail in previous publications [8, 
9]. Rats were individually placed in 50 × 40 x 22 cm polypropylene containers 
containing fresh pine-chip bedding which rested upon the platforms.  
Rats received 4 ECT exposures or exposure to all procedures with the exception of 
passage of  convulsive current (sham ECT). ECT parameters were: 0.2 sec of  60 Hz 
current at 400 V. Testing began 24-48 h after the final ECT or sham ECT exposure. 
Rats were individually habituated for 4 h, then briefly removed and injected, 1 
ml/kg,  intraperitoneally with vehicle or one of  two doses of  morphine sulfate. 
Activity was then recorded for 1 h in 10-min blocks. A separate group of  12 rats was 
injected with l0 m g / k g / d a y  of morphine for the 4-day period and tested as 
described above, and similarly tested 24-48 h after the last injection. This was a 
direct control for the demonstrat ion of reliable cross-tolerance effects within the 
drug condition. 
All data are presented as means and standard deviations. Statistical analysis was 
by 3-factor analysis of  variance, the factors being ECT vs sham, drug dosage (0.00, 
0.75, 1.50 mg/kg)  and time (minutes 0-60).  The last factor was corrected for 
repeated measures. 
Vehicle injections occasionally produced an acute activation lasting less than l0 
min. In contrast to vehicle, morphine injection was followed by a graded long- 
lasting behavioral activation which was present for most of  the testing interval. The 
normal degree of  opiate activation was blunted by ECT. These findings were 
confirmed as statistically reliable beyond chance levels. Main effects of  electroshock 
(F = 55.6; df = l, 67) and drug (F = 14.2; df  = 3, 67) were both significant (P < 
0.0001); however, the effect of  time (F -- 0.5; df  = 3,345) was not. Interactions of  
ECT and drug (F -- 4.7; df --- 2, 67), time and drug (F -- 1.9; df = 10, 345), time 
a n d E C T ( F  = 4.3; df = 5, 345) a n d 3  f a c t o r s ( F  = 2.4; df = 10, 345) were all 
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significant below a P < 0.05 criterion. The chronic (i.e. 10 mg/kg x 4) morphine- 
treated rats showed no activation effect to either test dose of  morphine: mean - 1 h 
score ( +  S.D.) for 0.75 and 1.5 mg/kg injected groups were 205 + 47 and 193 + 
32. Vehicle-treated rats scores were 48 + 29 (F < 1 no reliable differences from 
vehicle). Thus tolerance was demonstrated to the activating effects of  morphine and 
cross-tolerance of  ECT and morphine was also shown. 
The facts that ECT and drug administration both had reliable effects, and that 
they interacted in a statistically reliable manner, support the hypothesis that ECT 
affected the normal response to an opiate drug. These findings are consistent with 
the view that ECT exerts some of  its effects through the release of  endorphins, 
although this does not rule out the previously established contributions of other 
transmitter systems. 
One logical extension of an endorphin-mediated theory of ECT's  
psychobiological mode of  action is that depression may involve hypofunctions of  
endogenous opioid neuropeptides. Such a view is consistent with the theoretical 
positions of  other researchers [10] and with the observed clinical manifestations of  
affective disorders such as heightened pain and reduced pleasure. Depression may 
be a more complex phenomenon than can be accounted for by a single 
neurotransmitter malfunction, and the present hypothesis is not intended as an 
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Fig 1. Effects of sham treatment vs electroconvulswe shock on behavioral activation to opiates m the 
rat. Solid hnes are sham rats; broken lines are ECT-pretreated rats. All rats were administered 4 control 
or shock treatments, then tested for responses to vehicle or morphine. A 4 h habituation preceded drug 
rejection. Motor activity is presented as mean and standard deviation Insert m upper right indicates 
mean l0 mm scores across blocks, and demonstrates the shift to the right 
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In closing, it must be noted that these findings, although consistent with the 
hypothesized release of endogenous opioid neuropeptides by ECT, do not exclude 
additional effects by other neurotransmitters. Nor do they argue that the sole 
mediation of ECT's effects (including the reported tolerance effect) is exclusively 
opioid. Biogenic amines may play significant roles in tolerance development, 
including opioid tolerance. Finally, although endogenous opioids may be released, 
any therapeutic implications must also be viewed in the light of the reported 
tolerance effect. Development of tolerance argues that the functional significance of 
electroshock-induced release may be concomitantly reduced. This indeed would 
argue against a strtct endorphin hypofunction in depression. Both these findings 
and their qualifications suggest that additional tests of the functional significance of 
endogenous opiates in depressive syndromes should be considered. 
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